Vicarious Surgical Inc.
RBOT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $8 | $9 | $9 | $8 |
| G&A Expenses | $0 | $4 | $5 | $0 |
| SG&A Expenses | $4 | $4 | $6 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $14 | $16 | $14 |
| Operating Income | -$12 | -$14 | -$16 | -$15 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $1 |
| Pre-Tax Income | -$11 | -$13 | -$15 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$13 | -$15 | -$14 |
| % Margin | – | – | – | – |
| EPS | -1.86 | -2.23 | -2.6 | -2.36 |
| % Growth | 16.6% | 14.2% | -10.2% | – |
| EPS Diluted | -1.86 | -2.23 | -2.6 | -2.36 |
| Weighted Avg Shares Out | 6 | 6 | 6 | 6 |
| Weighted Avg Shares Out Dil | 6 | 6 | 6 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$11 | -$13 | -$15 | -$13 |
| % Margin | – | – | – | – |